Patents by Inventor John Tze-tzun Koh

John Tze-tzun Koh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8450374
    Abstract: Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: May 28, 2013
    Assignee: University of Delaware
    Inventors: John Tze-tzun Koh, Paula Lynn McGinley, Hongmu Pan, Robert Sikes
  • Publication number: 20100331418
    Abstract: Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.
    Type: Application
    Filed: June 29, 2010
    Publication date: December 30, 2010
    Inventors: John Tze-tzun KOH, Paula Lynn McGinley, Hongmu Pan, Robert Sikes
  • Patent number: 7807713
    Abstract: Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: October 5, 2010
    Assignee: University of Delaware
    Inventors: John Tze-tzun Koh, Paula Lynn McGinley, Hongmu Pan
  • Publication number: 20090270512
    Abstract: Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.
    Type: Application
    Filed: May 15, 2009
    Publication date: October 29, 2009
    Inventors: John Tze-tzun Koh, Paula Lynn McGinley, Hongmu Pan
  • Patent number: 7550505
    Abstract: Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: June 23, 2009
    Assignee: University of Delaware
    Inventors: John Tze-tzun Koh, Paula Lynn McGinley, Hongmu Pan